You can join FDA’s meeting on food chemical safety
How the U.S. and the FDA handle the nation's food supply and packaging has been in the spotlight more lately since former ...
STAT3 天
FDA introduces plan to assess safety of common chemicals added to food
After years of pressure, the FDA said it is strengthening its review of many chemical additives used to enhance color, ...
FiercePharma3 天
UPDATED: Experts support FDA's plan for restrictions on PD-1 drugs in stomach, esophageal ...
The days of broad stomach cancer labels for PD-1 inhibitors appear to be numbered.  | The days of broad stomach cancer labels ...
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
Opdivo (nivolumab) and Merck's (NYSE:MRK) Keytruda (pembrolizumab), two highly popular checkpoint inhibitors used in the ...
WBIW9 天
FDA and NIH joint public meeting on advancing smoking cessation priorities: Registration ...
INDIANA- On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, the U.S. Food and Drug Administration (FDA) and the National ...
ALS News Today5 天
Clene granted in-person FDA meeting on CNM-Au8 for ALS
Clene will have an in-person meeting with the FDA before the end of November to discuss a potential CNM-Au8 accelerated ...
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic ...
Applied Therapeutics stock rises as the FDA no longer requires an Advisory Committee meeting, keeping the Priority Review on ...
Targeted Oncology3 天
FDA ODAC Finds Limited Benefit for Checkpoint Inhibitors in Low PD-L1 Gastric Cancer
The FDA’s Oncologic Drug Advisory Committee voted against the use of checkpoint inhibitors in first-line advanced gastric ...
Investing4 天
CERo Therapeutics seeks FDA meeting, reshuffles leadershi
The company is actively seeking a Type A Meeting with the FDA to discuss the Investigational New Drug Application for CER-1236, which has been put on clinical hold due to two pharmacology and ...
Business Wire10 天
Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission
STOCKHOLM--(BUSINESS WIRE)--Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY), a pharmaceutical company leveraging its proprietary HyNap™ technology to develop enhanced cancer therapies, today ...
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and ...
For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...
West Virginia’s new drug czar was once addicted to opioids himself
Dr. Stephen Loyd, who has been treating patients with substance use disorder since he got sober two decades ago, says ...